These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 21864866)
1. Combined hypertriglyceridemic and insulin-glucose clamps for the characterization of substrate oxidation and plasma elimination of a long-chain triglyceride emulsion in healthy men. Åberg V; Thörne A; Alvestrand A; Nordenström J Metabolism; 2012 Feb; 61(2):221-8. PubMed ID: 21864866 [TBL] [Abstract][Full Text] [Related]
2. The hypertriglyceridemic clamp technique. Studies using long-chain and structured triglyceride emulsions in healthy subjects. Nordenström J; Thörne A; Aberg W; Carneheim C; Olivecrona T Metabolism; 2006 Nov; 55(11):1443-50. PubMed ID: 17046545 [TBL] [Abstract][Full Text] [Related]
3. Fat oxidation and plasma removal capacity of an intravenous fat emulsion in elderly and young men. Aberg W; Thörne A; Olivecrona T; Nordenström J Nutrition; 2006; 22(7-8):738-43. PubMed ID: 16815487 [TBL] [Abstract][Full Text] [Related]
4. Differential effects of acute hypertriglyceridemia on insulin action and insulin receptor autophosphorylation. Gumbiner B; Mucha JF; Lindstrom JE; Rekhi I; Livingston JN Am J Physiol; 1996 Mar; 270(3 Pt 1):E424-9. PubMed ID: 8638688 [TBL] [Abstract][Full Text] [Related]
5. Hyperlipidaemia is associated with increased insulin-mediated glucose metabolism, reduced fatty acid metabolism and normal blood pressure in transgenic mice overexpressing human apolipoprotein C1. Koopmans SJ; Jong MC; Que I; Dahlmans VE; Pijl H; Radder JK; Frölich M; Havekes LM Diabetologia; 2001 Apr; 44(4):437-43. PubMed ID: 11357474 [TBL] [Abstract][Full Text] [Related]
6. Relationship between insulin-mediated glucose disposal and lipid metabolism in man. Lillioja S; Bogardus C; Mott DM; Kennedy AL; Knowler WC; Howard BV J Clin Invest; 1985 Apr; 75(4):1106-15. PubMed ID: 3886702 [TBL] [Abstract][Full Text] [Related]
7. Whole-body substrate metabolism is associated with disease severity in patients with non-alcoholic fatty liver disease. Croci I; Byrne NM; Choquette S; Hills AP; Chachay VS; Clouston AD; O'Moore-Sullivan TM; Macdonald GA; Prins JB; Hickman IJ Gut; 2013 Nov; 62(11):1625-33. PubMed ID: 23077135 [TBL] [Abstract][Full Text] [Related]
8. Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM. Hübinger A; Knode O; Susanto F; Reinauer H; Gries FA Horm Metab Res; 1997 Sep; 29(9):436-9. PubMed ID: 9370111 [TBL] [Abstract][Full Text] [Related]
9. Glucose and fat utilization during intravenous administration of glucose and lipid emulsion in non-insulin-dependent diabetic patients. Pelikánová T; Krausová Z; Kohout M; Válek J; Basĕ J Nutrition; 1993; 9(1):18-22. PubMed ID: 8467106 [TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia prevents the suppressive effect of hyperinsulinemia on plasma adiponectin levels in healthy humans. Blümer RM; van der Crabben SN; Stegenga ME; Tanck MW; Ackermans MT; Endert E; van der Poll T; Sauerwein HP Am J Physiol Endocrinol Metab; 2008 Sep; 295(3):E613-7. PubMed ID: 18577692 [TBL] [Abstract][Full Text] [Related]
11. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients. van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393 [TBL] [Abstract][Full Text] [Related]
13. Metabolic changes in elderly cancer patients after glucose ingestion. The role of tumor necrosis factor-alpha. Gambardella A; Tortoriello R; Tagliamonte MR; Paolisso G; Varricchio M Cancer; 1997 Jan; 79(1):177-84. PubMed ID: 8988743 [TBL] [Abstract][Full Text] [Related]
14. Intramuscular triglyceride content is increased in IDDM. Ebeling P; Essén-Gustavsson B; Tuominen JA; Koivisto VA Diabetologia; 1998 Jan; 41(1):111-5. PubMed ID: 9498639 [TBL] [Abstract][Full Text] [Related]
15. Addition of n-3 fatty acids to a 4-hour lipid infusion does not affect insulin sensitivity, insulin secretion, or markers of oxidative stress in subjects with type 2 diabetes mellitus. Mostad IL; Bjerve KS; Basu S; Sutton P; Frayn KN; Grill V Metabolism; 2009 Dec; 58(12):1753-61. PubMed ID: 19716144 [TBL] [Abstract][Full Text] [Related]